Movement Disorders
Editat de A.G. Donald, N.S. Shahen Limba Engleză Paperback – 13 apr 2012
Preț: 728.69 lei
Preț vechi: 767.05 lei
-5% Nou
Puncte Express: 1093
Preț estimativ în valută:
139.46€ • 145.04$ • 116.70£
139.46€ • 145.04$ • 116.70£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781468450408
ISBN-10: 1468450409
Pagini: 428
Ilustrații: 424 p. 5 illus.
Dimensiuni: 178 x 254 x 22 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1986
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1468450409
Pagini: 428
Ilustrații: 424 p. 5 illus.
Dimensiuni: 178 x 254 x 22 mm
Greutate: 0.74 kg
Ediția:Softcover reprint of the original 1st ed. 1986
Editura: Springer Us
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Neuropharmacology of Movement Disorders: Comparison of Spontaneous and Drug-Induced Movement Disorders.- I. Parkinson’s Disease.- 1. Parkinsonism: Physiology and Pharmacology.- 2. Role of B-Type Monoamine Oxidase Inhibition in the Treatment of Parkinson’s Disease: An Update.- 3. Parkinson’s Disease: Current Concepts.- 4. The Clinical Evaluation of Drug Therapy in Parkinsonism and Models of Dysfunction of Brain Dopamine Systems in Animals: A Review.- II. Tardive Dyskinesia.- 5. Tardive Dyskinesia: Epidemiology, Pathophysiology, and Pharmacology.- 6. Tardive Dyskinesia and Subtyping of Schizophrenia.- 7. Brain Peptides, Neuroleptic-Induced Tolerance, and Dopamine Receptor Supersensitivity: Implications in Tardive Dyskinesia.- 8. Prevention of Tardive Dyskinesia.- 9. Clinical Aspects of Tardive Dyskinesia; Epidemiology, Natural History, and Management.- 10. Treatments for Tardive Dyskinesia: An Overview of Noncatecholaminergic/Noncholinergic Treatments.- III. Tourette Syndrome and Tic.- 11. Tourette Syndrome.- 12. Clinical Management of Tourette Syndrome with Clonidine.- 13. The Pathogenesis of Tourette Syndrome: A Review of Data and Hypotheses.- IV. Huntington’s Disease.- 14. Biochemical and Pharmacological Aspects of Movement Disorders in Huntington’s Disease.- 15. The Effects of Neuroleptics on Longevity in Huntington’s Disease.- V. Neuroleptic Drugs in the Production of Movement Disorders.- 16. Movement Disorders Induced by Neuroleptic Drugs.- 17. Movement Disorders and Neuroleptic Medication.- 18. Drug-Induced Movement Disorders.- 19. Movement Disorders Induced by Psychotherapeutic Agents: Clinical Features, Pathophysiology, and Management.- 20. Pharmacotherapy of Movement Disorders in Children and Adolescents.